Shire, AstraZeneca and Hikma hit by Hillary Clinton's pharma-bashing
25th Aug 2016 09:14
(ShareCast News) - Hikma Pharmaceuticals, Shire and AstraZeneca were among FTSE-listed drug companies slipping lower on Thursday morning, following comments from US presidential favourite Hillary Clinton on pharmaceutical pricing that hit peers across the Atlantic overnight. Clinton joined senators
Read moreGSK's ViiV joint venture begins testing new HIV treatment
16th Aug 2016 14:39
(ShareCast News) - GlaxoSmithKline's joint venture with Pfizer and Shionogi has begun testing a new two-drug treatment for HIV that looks to reduce the number of medicines people with the virus have to take. The ViiV Healthcare joint venture will test a two-drug regimen of dolutegravir (under the br
Read moreFriday broker round-up
12th Aug 2016 09:36
(ShareCast News) - Britvic: Berenberg reiterates buy with a target price of 775p. RSA Insurance: Deutsche Bank maintains hold with a 525p target. GlaxoSmithKline: JP Morgan reiterates neutral with a 1900p target. Amec Foster: Goldman Sachs stays at buy with a 691,1p target. A.G. Barr: Berenberg d
Read moreWednesday round-up
3rd Aug 2016 12:13
(ShareCast News) - Laird: UBS upgrades to buy with a target price of 350p. Direct Line Group: Deutsche Bank maintains buy with a 435p target. Associated British Foods: Exane BNP Paribas reiterates outperform with a 3300p target. Sky: Goldman Sachs reiterates buy with a target price of 1029p. Fres
Read moreGlaxoSmithKline links with Alphabet on new bioelectronics company
1st Aug 2016 07:09
(ShareCast News) - GlaxoSmithKline announced a new agreement on Monday, with Verily Life Sciences - formerly Google Life Sciences, an Alphabet company - to form Galvani Bioelectronics. The FTSE 100 firm said the partnership would enable the research, development and commercialisation of bioelectroni
Read moreGSK gives earnings guidance a shot in the arm after strong first half
27th Jul 2016 12:16
(ShareCast News) - GlaxoSmithKline said strong earnings growth in the second quarter led to expect full year earnings will hit the upper end of targets, with an extra boost coming from the weakness of sterling in the first half of the year. For the full year, GSK said it now expected core earnings p
Read moreGlaxoSmithKline to invest GBP275m in UK manufacturing sites
27th Jul 2016 10:06
(ShareCast News) - Amid growing concerns about how Brexit might affect investment in the UK, pharmaceuticals giant GlaxoSmithKline has announced plans to spend £275m on three of its UK manufacturing sites to boost production and support delivery of its latest respiratory and large molecule biologica
Read moreApple teams up with GlaxoSmithKline for ResearchKit project
19th Jul 2016 08:40
(ShareCast News) - Apple has stepped up its foray into the health technology world, teaming up with British firm GlaxoSmithKline for a project using ResearchKit, a medical platform for studies and clinical trials. The two companies will gather data from patients using an iOS app powered by ResearchK
Read moreCapita bumps up forecast for 2016 dividends, mid-caps to take Brexit hit
18th Jul 2016 12:28
(ShareCast News) - The fall in sterling following Brexit would deliver an immediate boost to the value of companies' dividend payments but potential recessionary pressures would hit profits and dividends from UK-focused mid-caps hardest, Capita said in its second quarter 2016 Dividend Monitor. De
Read moreBroker tips: GSK, Sage, Burberry
14th Jul 2016 10:39
(ShareCast News) - Shares in GlaxoSmithKline rose on Thursday as Jefferies upgraded the stock to 'buy' from 'hold' and lifted the target price to 2,000p from 1,650p. "We have upgraded GSK to 'buy' from 'hold' with a target price of 2,000p as we believe that the improving yield quality will continue
Read morePound weakness to boost Glaxo´s second quarter sales and EPS
11th Jul 2016 16:44
(ShareCast News) - The pound´s depreciation against the US dollar and Japanese yen during the second quarter of the year were set to significantly boost GlaxoSmithKline´s reported sales and profits in sterling terms, the company said. During the quarter ended on 30 June 2016 the pound had traded at
Read moreRedstoneConnect extends contract with GlaxoSmithKline
4th Jul 2016 13:40
(ShareCast News) - RedstoneConnect subsidiary Connect IB has extended its existing Site-Map application contract to GlaxoSmithKline's Asia headquarters. The deal would see the roll-out of Site Map at one of GSK's existing Singapore locations and a future roll-out in 2017 at GSK's new global headquar
Read moreSunday share tips: EasyJet, Randgold, Imperial Brands, AstraZeneca
26th Jun 2016 14:03
(ShareCast News) - Sell EasyJet shares due to the likely turbulence sparked by the Brexit vote, said the Sunday Times' Inside the City column. The budget airline was created by Stelios Haji-Ioannou in the wake of the 1992 European Union Treaty on Open Skies, one of the supposedly rare bits of Brusse
Read moreLeave vote would have limited impact on FTSE, says SpreadCo analyst
21st Jun 2016 13:12
(ShareCast News) - Although consensus is that the FTSE 100 will rally if voters in the UK opt to remain in the European Union on Thursday and sell off on a Leave vote, the overall impact of an exit on London stocks may be limited, said SpreadCo analyst David Morrison. "The damage to the FTSE100 as a
Read moreLondon midday: Financials pace gains as Footsie keeps climbing
20th Jun 2016 12:29
(ShareCast News) - Stocks in London were continuing to move higher come midday on Monday, alongside the largest gain the pound in three months, with investors taking their cue from strong gains in Asia as Brexit polls showed the Remain campaign was in the lead. As of 12:03 BST, the FTSE 100 was 183.
Read more